11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 424B3 | |
11/17/2024 11:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form EFFECT | |
11/14/2024 5:45 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/14/2024 5:45 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/05/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
|
11/05/2024 11:42 AM | Cherington Charles (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Brooklyn ImmunoTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form ARS | |
09/27/2024 3:47 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form PRE 14A | |
09/27/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 3:36 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 4:00 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024 3:32 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Brooklyn ImmunoTherapeutics (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 4:14 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 10-K/A | |
02/16/2024 4:30 PM | Cicala Peter (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics Inc. (Issuer) Brooklyn ImmunoTherapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/16/2024 6:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 6:05 AM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) Brooklyn ImmunoTherapeutics (Subject) HALPERN JOHN D (Filed by)
| Form SC 13G/A | |
01/22/2024 11:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form EFFECT | |
01/19/2024 9:31 AM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) Brooklyn ImmunoTherapeutics (Subject) Singer Nicholas Jason (Filed by)
| Form SC 13G/A | |
01/12/2024 3:49 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics Inc. (Filer) Brooklyn ImmunoTherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/22/2023 11:05 AM | Cherington Charles (Filed by) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics Inc. (Subject) Brooklyn ImmunoTherapeutics (Subject)
| Form SC 13D/A | |